151 related articles for article (PubMed ID: 30219657)
41. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
42. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
43. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
44. Detectability of Malignant Lesions by Whole-Body Magnetic Resonance Imaging Using Whole-Body Integrated Positron Emission Tomography/Magnetic Resonance Imaging.
Ishii S; Miyajima M; Suenaga H; Sugawara S; Nemoto A; Ukon N; Nambu T; Kubo H; Oriuchi N; Ito H
J Comput Assist Tomogr; 2019; 43(4):664-670. PubMed ID: 31259851
[TBL] [Abstract][Full Text] [Related]
45. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
[TBL] [Abstract][Full Text] [Related]
46. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
[TBL] [Abstract][Full Text] [Related]
47. Comparison of T2-weighted imaging, diffusion-weighted imaging and contrast-enhanced T1-weighted MR imaging for evaluating perianal fistulas.
Baik J; Kim SH; Lee Y; Yoon JH
Clin Imaging; 2017; 44():16-21. PubMed ID: 28395191
[TBL] [Abstract][Full Text] [Related]
48. Volumetric and semiquantitative assessment of MRI-detected subchondral bone marrow lesions in knee osteoarthritis: a comparison of contrast-enhanced and non-enhanced imaging.
Roemer FW; Khrad H; Hayashi D; Jara H; Ozonoff A; Fotinos-Hoyer AK; Guermazi A
Osteoarthritis Cartilage; 2010 Aug; 18(8):1062-6. PubMed ID: 20472082
[TBL] [Abstract][Full Text] [Related]
49. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
Mosavi F; Laurell A; Ahlström H
Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
[TBL] [Abstract][Full Text] [Related]
50. Peribiliary liver metastases MR findings.
Granata V; Fusco R; Catalano O; Avallone A; Leongito M; Izzo F; Petrillo A
Med Oncol; 2017 Jul; 34(7):124. PubMed ID: 28573638
[TBL] [Abstract][Full Text] [Related]
51. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection.
Brenner R; Metens T; Bali M; Demetter P; Matos C
Eur J Radiol; 2012 May; 81(5):e746-9. PubMed ID: 22386133
[TBL] [Abstract][Full Text] [Related]
53. Relative value of three whole-body MR approaches for PET-MR, including gadofosveset-enhanced MR, in comparison to PET-CT.
Obara P; Loening A; Taviani V; Iagaru A; Hargreaves BA; Vasanawala S
Clin Imaging; 2018; 48():62-68. PubMed ID: 29031209
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
Grueneisen J; Sawicki LM; Wetter A; Kirchner J; Kinner S; Aktas B; Forsting M; Ruhlmann V; Umutlu L
Eur J Radiol; 2017 Apr; 89():14-19. PubMed ID: 28267530
[TBL] [Abstract][Full Text] [Related]
55. Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: analysis of a series of 97 cases.
Akkari M; Gabrillargues J; Saroul N; Pereira B; Russier M; Mom T; Gilain L
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):153-8. PubMed ID: 24709404
[TBL] [Abstract][Full Text] [Related]
56. [Values of diffusion-weighted magnetic resonance imaging in the early detection of periventricular leukomalacia in preterm infants].
Fu JH; Xue XD; Fan GG; You K; Ren Y
Zhonghua Er Ke Za Zhi; 2008 May; 46(5):354-8. PubMed ID: 19099752
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.
Reginelli A; Granata V; Fusco R; Granata F; Rega D; Roberto L; Pellino G; Rotondo A; Selvaggi F; Izzo F; Petrillo A; Grassi R
Oncotarget; 2017 Apr; 8(14):22980-22990. PubMed ID: 28152518
[TBL] [Abstract][Full Text] [Related]
58. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
59. Comparison of computed tomographic urography, magnetic resonance urography and the combination of diffusion weighted imaging in diagnosis of upper urinary tract cancer.
Wu GY; Lu Q; Wu LM; Zhang J; Chen XX; Xu JR
Eur J Radiol; 2014 Jun; 83(6):893-899. PubMed ID: 24656880
[TBL] [Abstract][Full Text] [Related]
60. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
